IFM Investors’s Legend Biotech LEGN Stock Holding History

IFM Investors’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,476	Closed	-$81K	–	671
2026 Q1	$81K	Buy	+4,476	New	+$85.3K	﹤0.01%	657
2024 Q2	–	Sell	-3,712	Closed	-$208K	–	697
2024 Q1	$208K	Buy	+3,712	New	+$224K	﹤0.01%	620
2023 Q4	–	Sell	-3,712	Closed	-$249K	–	604
2023 Q3	$249K	Hold	3,712	–	–	﹤0.01%	631
2023 Q2	$256K	Sell	3,712 -4,571	-55%	-$299K	﹤0.01%	632
2023 Q1	$399K	Buy	8,283 +657	+9%	+$32.1K	0.01%	612
2022 Q4	$381K	Buy	+7,626	New	+$369K	0.01%	605

Other funds holding LEGN

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ELI

Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

EFMH

E Fund Management (HK) Central, Hong Kong $302M AUM 64.42% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

TPSF

Texas Permanent School Fund Austin, Texas $2.26B AUM 7.02% 1-Year Est. Return

YMRC

Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

IFM Investors's LEGN Position: Q2 2026 in Review

IFM Investors sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 4,476 shares — an estimated $81K sold.

IFM Investors first reported a position in LEGN in Q4 2022 and held it in 6 quarters. The position peaked at $399K in Q1 2023. 31 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

IFM Investors reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
IFM Investors sold 4,476 Legend Biotech shares in Q2 2026, an estimated $81K.
IFM Investors first reported a position in Legend Biotech in Q4 2022 and held it in 6 quarters.
IFM Investors's Legend Biotech position peaked at $399K in Q1 2023.
31 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.